Silvercrest Asset Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
Silvercrest Asset Management's ZYME Position: Q3 2026 in Review
Silvercrest Asset Management increased its Zymeworks (ZYME) stake by 23% in Q3 2026, buying an estimated $1.35M and bringing the position to 276,038 shares worth $7.31M. The position accounts for 0.05% of the portfolio, ranked #388.
Silvercrest Asset Management first reported a position in ZYME in Q4 2020 and has held it in 20 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.
- Silvercrest Asset Management held 276,038 shares of Zymeworks worth $7.31M as of Q3 2026.
- Silvercrest Asset Management bought 52,272 Zymeworks shares in Q3 2026, an estimated $1.35M.
- Zymeworks made up 0.05% of Silvercrest Asset Management's portfolio in Q3 2026, its #388 holding.
- Silvercrest Asset Management first reported a position in Zymeworks in Q4 2020 and has held it in 20 quarters since.
- 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.
Based on Silvercrest Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.